Related Experiment Video
Updated: Jun 30, 2026
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
3.8K
Present and Future Surgical Options for Tricuspid Regurgitation
Ana Paula Tagliari1,2, Maurizio Taramasso3
1Instituto de Ciências Biológicas e da Saúde, Universidade Federal do Rio Grande do Sul, 90046-900 Porto Alegre, Brazil.
Reviews in Cardiovascular Medicine
|July 30, 2024
Summary
Tricuspid regurgitation (TR) is increasingly recognized for its significant impact. This review explores current and future surgical management strategies for severe TR, including indications and clinical trials.
Area of Science:
- Cardiology
- Cardiac Surgery
- Clinical Medicine
Background:
- Tricuspid regurgitation (TR) was historically underestimated but is now recognized for its significant impact on patient outcomes.
- Current guidelines offer Class I indications for surgical intervention in limited scenarios of severe TR.
- Advances in understanding TR's prognosis necessitate a re-evaluation of management strategies.
Purpose of the Study:
- To review the current landscape of surgical tricuspid regurgitation management.
- To examine the prognosis, indications, and outcomes associated with surgical TR intervention.
- To provide an overview of ongoing and future clinical trials in surgical TR management.
Main Methods:
- Literature review of current guidelines and clinical evidence.
- Analysis of prognostic factors and surgical outcomes in tricuspid regurgitation.
- Survey of completed, ongoing, and planned clinical trials related to surgical TR.
Main Results:
- Severe tricuspid regurgitation significantly impacts short- and long-term patient follow-up.
- Surgical intervention is the standard for severe TR but indications are currently restrictive.
- Numerous clinical trials are investigating expanded indications and novel approaches for surgical TR.
Conclusions:
- The management of tricuspid regurgitation requires a nuanced approach considering evolving evidence.
- Future research and clinical trials are crucial for refining surgical indications and improving outcomes.
- Optimizing surgical management of TR is essential for improving patient prognosis.
More Related Videos
Related Concept Videos
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:28Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...